Interim results of a phase I trial suggests that 'Tomudex' (raltitrexed) may act synergistically with 5-FU in patients with advanced colorectal cancer (CRC) Meeting Abstract


Authors: Schwartz, G. K.; Bertino, J. L.; Kemeny, N.; Saltz, L.; Sugarman, A.; Kelsen, D. K.; Tong, W.; Lowery, C.; Smith, M.
Abstract Title: Interim results of a phase I trial suggests that 'Tomudex' (raltitrexed) may act synergistically with 5-FU in patients with advanced colorectal cancer (CRC)
Meeting Title: 23rd Congress of the European Society for Medical Oncology (ESMO)
Journal Title: Annals of Oncology
Volume: 9
Issue: Suppl. 4
Meeting Dates: 1998 Nov 6-10
Meeting Location: Athens, Greece
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 1998-01-01
Start Page: 36
Language: English
ACCESSION: WOS:000076947100172
PROVIDER: wos
PUBMED: 9894505
Notes: Meeting Abstract: 171P -- Source: Wos
Citation Impact
MSK Authors
  1. William Ping-Yiu Tong
    158 Tong
  2. Leonard B Saltz
    790 Saltz
  3. Gary Schwartz
    385 Schwartz
  4. Joseph Bertino
    363 Bertino
  5. David P Kelsen
    537 Kelsen
  6. Nancy Kemeny
    543 Kemeny